Literature DB >> 519436

Proximal myopathy during beta-blockade.

J C Forfar, G J Brown, R E Cull.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 519436      PMCID： PMC1597321          DOI： 10.1136/bmj.2.6201.1331

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  2 in total

1.  Possible propranolol-myotonin association.

Authors:  S Satya-Murti; T Heiman; L B Martinez
Journal:  N Engl J Med       Date:  1977-07-28       Impact factor: 91.245

2.  Myotonia precipitated by propranolol therapy.

Authors:  W Blessing; J C Walsh
Journal:  Lancet       Date:  1977-01-08       Impact factor: 79.321
  2 in total
  6 in total

1.  Evaluation of antihypertensive drugs in combination with enzyme replacement therapy in mice with Pompe disease.

Authors:  Sang-Oh Han; Alexina C Haynes; Songtao Li; Dennis M Abraham; Priya S Kishnani; Richard Steet; Dwight D Koeberl
Journal:  Mol Genet Metab       Date:  2019-10-17       Impact factor: 4.797

Review 2.  Adverse effects of antihypertensive drugs.

Authors:  F E Husserl; F H Messerli
Journal:  Drugs       Date:  1981-09       Impact factor: 9.546

Review 3.  Adverse effects of drugs on muscle.

Authors:  F L Mastaglia
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

4.  Selective beta-adrenoceptor partial agonist effects of pindolol and xamoterol on skeletal muscle assessed by plasma creatine kinase changes in healthy subjects.

Authors:  B Tomlinson; J M Cruickshank; Y Hayes; J C Renondin; J B Lui; B R Graham; A Jones; A D Lewis; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1990-11       Impact factor: 4.335

5.  Bucindolol: effects on blood pressure, airways resistance and serum creatine phosphokinase.

Authors:  J S Gill; D G Beevers
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Muscle cramps and elevated serum creatine phosphokinase levels induced by beta-adrenoceptor blockers.

Authors:  Y Imai; N Watanabe; J Hashimoto; A Nishiyama; H Sakuma; H Sekino; K Omata; K Abe
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.